February 15, 2006 -- NOF statement in response to the Women’s Health Initiative (WHI) findings outlined in the *New England Journal of Medicine article, “Calcium plus Vitamin D Supplementation and the Risk of Fractures:"
The recently reported WHI findings related to calcium and vitamin D raise key points about maintaining optimal bone health. NOF reminds all women that while calcium and vitamin D play an important role in maintaining bone health, they are not the only steps to take.
NOF continues to recommend Five Steps to Bone Health:
January 6, 2006 – Osteoporosis is a serious, widespread and growing public health threat, according to the National Osteoporosis Foundation (NOF). NOF welcomes any new FDA approved treatment options, such as Boniva Injection®, that will help patients address this all too prevalent disease. NOF estimates 44 million American women and men age 50 and older are at risk of breaking a bone due to osteoporosis and low bone mass.
(Washington, DC) November 2, 2005 – Their Royal Highnesses The Duchess of Cornwall accompanied by The Prince of Wales will meet with the National Osteoporosis Foundation (NOF) and several of the Foundation’s patient champions onThursday, November 3, 2005 during a meeting at the National Institutes of Health. The meeting will focus on increasing awareness of osteoporosis, a disease which the U.S. Surgeon General has recognized as a growing public health threat in his landmark report released in 2004.
August 15, 2005 – Osteoporosis is a serious, widespread and growing public health threat, according to the National Osteoporosis Foundation (NOF). NOF welcomes any new FDA approved treatment options, such as Actonel Plus Calcium®, that will help patients address this all too prevalent disease. NOF estimates 44 million American women and men age 50 and older are at risk of breaking a bone due to osteoporosis and low bone mass.
August 15, 2005 – Osteoporosis is a serious, widespread and growing public health threat, according to the National Osteoporosis Foundation (NOF). NOF welcomes any new FDA cleared diagnostic options, such as the Elecsys N-MID Osteocalcin test, that will help patients address this all too prevalent disease. NOF estimates 44 million American women and men age 50 and older are at risk of breaking a bone due to osteoporosis and low bone mass.
July 27, 2005 (Washington, DC) – The National Osteoporosis Foundation (NOF) announces that, as of July 21, Ethel S. Siris, MD, has begun her term as NOF President. Additionally, NOF announced the election of Sundeep Khosla, MD, to the newly created office of Vice President. Dr. Siris’ term follows the completion of three years of distinguished service as NOF President by Dr. Bess Dawson-Hughes of the USDA Human Nutrition Research Center on Aging, Tufts University, who remains on the NOF Board of Trustees as Immediate Past President.
Raising awareness of osteoporosis - - a disease that will affect one in two women and one in four men aged 50 and older in the United States -- was the focus of the National Osteoporosis Foundation's (NOF) 10thgala on Tuesday, May 24, 2005. All of the honorees that were recognized are strong advocates for osteoporosis awareness and include:
Her Royal Highness The Duchess of Cornwall (who accepted via video message)
(Washington, D.C.) October 19, 2005 – The National Osteoporosis Foundation (NOF) is joining organizations around the world in recognizing World Osteoporosis Day on October 20th to help raise awareness about the important role of exercise in building peak bone mass and maintaining bone health.
April 5, 2005 (Washington, DC) – The National Osteoporosis Foundation (NOF) is bringing together a faculty of internationally-renowned experts to share state-of-the-art information and research on bone health and osteoporosis prevention, diagnosis and treatment with hundreds of physicians and other healthcare professionals at the Sixth International Symposium on Osteoporosis (ISO), April 6-10, at the Marriott Wardman Park Hotel in Washington, DC “Current Status & Future Directions” is the only biennial scientific meeting in the United States to focus on osteoporosis an
March 25, 2005 -- “Osteoporosis is a serious, widespread and growing public health threat. We welcome any new treatment options such as Boniva that will help patients address this all too prevalent disease,” said Judith Cranford, Executive Director, National Osteoporosis Foundation.